N-Acetylcysteine, an ROS Inhibitor, Alleviates the Pathophysiology of Hyperthyroidism-Induced Cardiomyopathy via the ROS/Ca(2+) Pathway

Hyperthyroidism is common and can induce cardiomyopathy, but there is no effective therapeutic strategy. The purpose of this study was to investigate the molecular mechanism of hyperthyroidism-induced cardiomyopathy (HTC) and the effect of N-acetylcysteine (NAC), an ROS inhibitor, on the pathophysio...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Mengni, Hua, Xiumeng, Mo, Han, Sun, Zhe, Xu, Bo, Chen, Xiao, Xu, Mengda, Xu, Xinjie, Song, Jiangping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496499/
https://www.ncbi.nlm.nih.gov/pubmed/36139036
http://dx.doi.org/10.3390/biom12091195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496499/
https://www.ncbi.nlm.nih.gov/pubmed/36139036
http://dx.doi.org/10.3390/biom12091195

Ejemplares similares